FMP

FMP

Enter

PFE - Pfizer Inc.

photo-url-https://images.financialmodelingprep.com/symbol/PFE.png

Pfizer Inc.

PFE

NYSE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

22.28 USD

-0.69 (-3.1%)

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

12.22B

31.07B

22.73B

12.69B

20.48B

22.18B

26.87B

32.54B

39.41B

47.73B

Total Cash %

29.16

38.22

22.66

21.69

32.18

28.78

28.78

28.78

28.78

Receivables

7.91B

11.48B

10.95B

11.18B

14.78B

13.29B

16.1B

19.5B

23.62B

28.61B

Receivables %

18.88

14.12

10.92

19.11

23.22

17.25

17.25

17.25

17.25

Inventories

8.05B

9.06B

8.98B

10.19B

10.85B

11.37B

13.77B

16.68B

20.2B

24.47B

Inventories %

19.2

11.14

8.95

17.42

17.05

14.75

14.75

14.75

14.75

Payable

4.28B

5.58B

6.81B

6.71B

5.63B

6.81B

8.25B

9.99B

12.1B

14.66B

Payable %

10.22

6.86

6.79

11.47

8.85

8.84

8.84

8.84

8.84

Cap Ex

-2.79B

-2.71B

-3.24B

-3.91B

-2.91B

-3.77B

-4.57B

-5.53B

-6.7B

-8.12B

Cap Ex %

-6.66

-3.34

-3.23

-6.68

-4.57

-4.89

-4.89

-4.89

-4.89

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep